J Gómez-Arnau, A Criado, R Burgos, R Horno, J Agosti
{"title":"Iatrogenic myocardial dysfunction after formalization of the heart.","authors":"J Gómez-Arnau, A Criado, R Burgos, R Horno, J Agosti","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>A 20-year-old patient with myoepicardial echinococcosis was referred to our hospital for surgical treatment. After polycystectomy had been performed, the surgical area was mistakenly washed with formaldehyde solution, and severe myocardial dysfunction ensued. Histological alterations were compatible with toxic cellular damage.</p>","PeriodicalId":84396,"journal":{"name":"Cardiovascular diseases","volume":"8 4","pages":"558-561"},"PeriodicalIF":0.0,"publicationDate":"1981-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC288003/pdf/cardiodis00004-0098.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"24582023","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Kevin J. McBride, Thomas F. O'Donnell, Stephen G. Pauker, Victor A. Millan, Allan D. Callow
{"title":"Venous volume displacement plethysmography: Its diagnostic value in deep venous thrombosis as determined by receiver operator characteristic curves.","authors":"Kevin J. McBride, Thomas F. O'Donnell, Stephen G. Pauker, Victor A. Millan, Allan D. Callow","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>The pitfall of several reviews of noninvasive venous assessment has been the expression of the test data solely in terms of diagnostic accuracy (the number of correct tests in ratio to all tests performed), where results of a test will vary according to disease prevalence. The advantages of receiver operator characteristic curve analysis are twofold: (1) it describes the dynamic relationship between sensitivity (the ratio of the number of true positive tests to the patients with deep venous thrombosis) and specificity (the ratio of true negative tests to the number of patients with no deep venous thrombosis) independent of disease prevalence; and (2) the threshold criteria that defines a positive test can be set by the best balance between sensitivity and specificity and then applied to a given patient population for its diagnostic accuracy. Venous volume plethysmography is a widely used, simple and rapid method. It was compared to the \"gold standard\" of phlebography in a prospective blind study of 70 limbs that were clinically suspect of having deep venous thrombosis (DVT). Venous volume displacement plethysmography was defined objectively by three quantitative parameters: (1) maximum venous outflow, (2) integer ratio, and (3) segmental venous capacitance ratio. The DVT (22 to 70 positive phlebograms) was divided by anatomic location into either calf vein DVT or proximal DVT (popliteal vein or above). By combining these three parameters, a balance between sensitivity and specificity was obtained to provide a rapid, objective method for screening patients with suspected DVT.</p>","PeriodicalId":84396,"journal":{"name":"Cardiovascular diseases","volume":"8 4","pages":"499-508"},"PeriodicalIF":0.0,"publicationDate":"1981-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC287989/pdf/cardiodis00004-0039.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"24582015","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
A Addison Barman, William Batiuchok, Saqib S. Chaudry, John J. Creedon
{"title":"Use of interposed polytetrafluorethylene (PTFE) graft in distal splenorenal shunt.","authors":"A Addison Barman, William Batiuchok, Saqib S. Chaudry, John J. Creedon","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Two patients with massive upper gastrointestinal hemorrhages required transsplenic decompression of the esophageal varices, but because technical difficulties precluded tension-free anastomoses, interposition of PTFE grafts was used to solve these difficult situations.</p>","PeriodicalId":84396,"journal":{"name":"Cardiovascular diseases","volume":"8 4","pages":"555-557"},"PeriodicalIF":0.0,"publicationDate":"1981-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC288001/pdf/cardiodis00004-0095.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"24582022","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
R Park Carmon, Cristine C. Clay, Trudi Stafford, Charles C. Reed
{"title":"A clinical trial of the Bentley BOS-5 pediatric oxygenator.","authors":"R Park Carmon, Cristine C. Clay, Trudi Stafford, Charles C. Reed","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>The performance of the Bentley BOS-5 pediatric oxygenator was evaluated on the basis of its response to maintain arterial pH between 7.35 and 7.45, arterial pO(2) between 100 and 200 mm Hg, and arterial pCO(2) between 35 and 45 mm Hg (Texas Heart Institute perfusion protocol). The oxygenator was found to be efficient at all flow rates employed; however, the pO(2) parameter could not be consistently maintained within protocol limits, but could be improved when a mixture of 5% carbon dioxide/95% oxygen was used for the duration of a case.</p>","PeriodicalId":84396,"journal":{"name":"Cardiovascular diseases","volume":"8 4","pages":"562-566"},"PeriodicalIF":0.0,"publicationDate":"1981-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC288004/pdf/cardiodis00004-0102.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"24582024","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Charles C. Reed, Kenneth P. Malloy, Diane K. Clark
{"title":"Evaluation of a new modified pediatric bubble oxygenator.","authors":"Charles C. Reed, Kenneth P. Malloy, Diane K. Clark","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>A comparison was made of the S-070 Pediatric Bubble Oxygenator, which was unreliable above flow rates of approximately 1.5 L/min, with a modified S-070A, which proved to be extremely efficient to flow rates of 2.5 L/min.</p>","PeriodicalId":84396,"journal":{"name":"Cardiovascular diseases","volume":"8 4","pages":"569-574"},"PeriodicalIF":0.0,"publicationDate":"1981-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC288007/pdf/cardiodis00004-0109.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"24582026","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Michael A. Graham, Donald B. Butler, John D. Milam
{"title":"Thoracic aortic thrombi and hypercoagulability.","authors":"Michael A. Graham, Donald B. Butler, John D. Milam","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>This unusual report shows the association between thoracic aortic mural thrombus formation and the hypercoagulable state without concomitant disseminated intravascular coagulation. The patient's hypercoagulability was reflected by laboratory results that included elevated Factor VIII and fibrinogen levels, along with a decreased level of antithrombin III. The underlying cause was probably acute peritonitis, a condition associated with coagulopathy.</p>","PeriodicalId":84396,"journal":{"name":"Cardiovascular diseases","volume":"8 4","pages":"475-479"},"PeriodicalIF":0.0,"publicationDate":"1981-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC287985/pdf/cardiodis00004-0015.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"24582186","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Adolph J Koska, Alexander Romagnoli, William G. Kramer
{"title":"Pharmacodynamics of fentanyl citrate in patients undergoing aortocoronary bypass.","authors":"Adolph J Koska, Alexander Romagnoli, William G. Kramer","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>The pharmacodynamics of fentanyl citrate were studied in two groups of patients. One group underwent surgery with cardiopulmonary bypass (CPB) and the other group had surgery without CPB; the latter group represented the controls. Apneic periods were considerably longer (2.70 +/- 0.90 hr) for the CPB patients than for the control patients (1.75 +/- 0.75 hr). The total plasma fentanyl concentration at which apnea ceased was not statistically different between the two groups. Minor differences were attributed to the massive dilution of plasma proteins after the adding of priming fluid to the heart-lung machine. This prolongation of apnea is of considerable clinical importance because it means that CPB patients must remain mechanically ventilated for longer periods.</p>","PeriodicalId":84396,"journal":{"name":"Cardiovascular diseases","volume":"8 3","pages":"405-412"},"PeriodicalIF":0.0,"publicationDate":"1981-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC287964/pdf/cardiodis00003-0108.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"24581350","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Increased release of beta thromboglobulin during acute myocardial infarction.","authors":"Richard E. Ward, Jannie Woo, Paul Pace","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Beta thromboglobulin (betaTG) is a platelet-specific protein released during platelet aggregation. To classify the role of platelet aggregation in acute myocardial infarction (AMI), betaTG levels were measured by means of a specific and highly sensitive radioimmunoassay in patients admitted to the Coronary Care Unit for the evaluation of acute chest pain. These levels were compared to creatine phosphokinase (CPK) values and the percentage of myocardial fraction (MB), as well as electrocardiographic criteria for AMI. Beta thromboglobulin was considered elevated when it was greater than 132 micro/1. The CPK and MB fraction were considered to indicate AMI if there was an increase of MB fraction greater than 5% of the total CPK and a progressive increase of the total CPK and MB fraction during the course of the disease. Ten patients were compared to 28 control subjects. Seven patients had electrocardiographic evidence of AMI in addition to CPK and MB criteria. Six of these patients also had elevated betaTG values, whereas one did not. This patient was admitted late during his clinical course, as evidenced by the CPK-MB curve. Of the three patients without clinical evidence of AMI, two had normal betaTG levels, whereas the third patient had one normal betaTG level and one mildly elevated level. This study implicates the role of platelet aggregation in AMI and suggests its potential usefulness as a diagnostic aid in evaluating acute chest pain.</p>","PeriodicalId":84396,"journal":{"name":"Cardiovascular diseases","volume":"8 3","pages":"372-378"},"PeriodicalIF":0.0,"publicationDate":"1981-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC287958/pdf/cardiodis00003-0075.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"24581346","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Calcium antagonists: A new class of therapeutic agents.","authors":"Antonius Gunawan, Ali Massumi, Robert J. Hall","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>A new class of therapeutic agents, sharing inhibition of the slow calcium channel, will soon be available to the American patient. Selective action of these agents upon the atrioventricular node, the smooth muscle of coronary and peripheral arteries, and the contractility of cardiac muscle opens new vistas in cardiovascular pharmacology. Early release of these agents by the Federal Drug Administration for general use is urged, based upon the already wide and successful experience in the European and South American continents.</p>","PeriodicalId":84396,"journal":{"name":"Cardiovascular diseases","volume":"8 3","pages":"413-420"},"PeriodicalIF":0.0,"publicationDate":"1981-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC287966/pdf/cardiodis00003-0116.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"24581351","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
S Bert Litwin, Samir K. Mitra, Rochelle Von Colditz, John Von Colditz, Linda B. Hamilton, Terrance McManus, Hani G. Jume'an, Jack Lazerson
{"title":"Use of activated clotting time for monitoring anticoagulation during cardiopulmonary bypass in infants and children with congenital heart disease.","authors":"S Bert Litwin, Samir K. Mitra, Rochelle Von Colditz, John Von Colditz, Linda B. Hamilton, Terrance McManus, Hani G. Jume'an, Jack Lazerson","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>The use of a fixed dosage schedule was compared with the use of activated clotting time (ACT) for determining heparin and protamine dosages during and after cardiopulmonary bypass disease. Use of the ACT resulted in a statistically significant increase in heparin dosage and a statistically significant reduction of postoperative blood loss. With ACT use, chest tubes were retained for a shorter period of time, and the incidence of serious postoperative hemorrhage was reduced from 44% to 18%. These results confirm the superiority of the ACT method for monitoring intraoperative anticoagulation in pediatric patients with congenital heart disease.</p>","PeriodicalId":84396,"journal":{"name":"Cardiovascular diseases","volume":"8 3","pages":"364-371"},"PeriodicalIF":0.0,"publicationDate":"1981-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC287956/pdf/cardiodis00003-0067.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"24581345","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}